Asia-Pacific markets mostly higher as investors assess China GDP and inflation targets

Asia-Pacific markets mostly higher as investors assess China GDP and inflation targets


A man carrying a kite in the shape of the Chinese national flag walks along the Bund while buildings of Pudong’s Lujiazui financial district  in Shanghai, China

Bloomberg | Bloomberg | Getty Images

Asia-Pacific markets were mostly higher Wednesday as investors assessed China growth and inflation targets amid U.S. tariffs and escalating global trade tensions weighing down sentiment.

Australia’s S&P/ASX 200 fell 0.70% to close at 8,141.1. Australia’s economy expanded 1.3% year on year in the fourth quarter, beating expectations of 1.2% from economists polled by Reuters.

Japan’s Nikkei 225 added 0.29% while the Topix climbed 0.38%. South Korea’s Kospi rose 1.22% while the small-cap Kosdaq advanced 1.24%.

Hong Kong’s Hang Seng Index added 2.43%, while mainland China’s CSI 300 rose 0.45%.

Investors are also focused on China’s “Two Sessions,” an annual parliamentary gathering, with the meeting of its top legislature, the National People’s Congress, kickstarting Wednesday.

China on Wednesday set its GDP growth target for 2025 at around 5%. The country has also lowered its inflation expectations to “around 2%.”

Trump’s 25% tariffs on goods from Mexico and Canada took effect Tuesday. The president also imposed an additional 10% duty on Chinese goods, bringing the total new tariffs on China to 20%.

Overnight in the U.S., the three major averages closed lower. The Dow Jones Industrial Average tumbled for a second day, dropping 670.25 points, or 1.55% and ended the session at 42,520.99. The S&P 500 dropped 1.22% to close at 5,778.15 after notching its worst day of the year in the prior session. The Nasdaq Composite lost 0.35% and finished at 18,285.16.

—CNBC’s Lisa Kailai Han and Alex Harring contributed to this report.



Source

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections
World

Novo Nordisk sues Hims & Hers over cheaper copycat versions of Wegovy pill, injections

The logo of pharmaceutical company Novo Nordisk is displayed in front of its offices in Bagsvaerd, Copenhagen, Denmark, February 4, 2026. Tom Little | Reuters Novo Nordisk on Monday said it is suing online telehealth provider Hims & Hers for mass marketing cheaper, unapproved copies of the drugmaker’s new Wegovy obesity pill and injections in […]

Read More
Stock futures nudge lower as Wall Street awaits closely watched jobs, inflation reports: Live updates
World

Stock futures nudge lower as Wall Street awaits closely watched jobs, inflation reports: Live updates

A trader works as the Dow Jones Industrial Average surpasses the 50,000 mark on the floor at the New York Stock Exchange (NYSE) in New York City, U.S., Feb. 6, 2026. Brendan McDermid | Reuters U.S. equity futures were slightly lower on Monday as investors awaited critical economic data and another batch of earnings reports […]

Read More
U.S. Treasury yields move higher as investors await busy week of economic data
World

U.S. Treasury yields move higher as investors await busy week of economic data

Traders work at the New York Stock Exchange on Jan. 27, 2026. NYSE U.S. Treasury yields were up to begin the week as investors looked ahead to a flurry of economic data, including the delayed January jobs report. The 10-year Treasury yield was up 3 basis points at 4.236%, and the 30-year Treasury yield was more than 3 basis […]

Read More